Recorlev 150 mg/1
Levoketoconazole · TABLET · Xeris Pharmaceuticals, Inc.
No Recall History
Plain English
Recorlev is a tablet containing levoketoconazole at 150 mg/1, taken oral. Manufactured by Xeris Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Recorlev
- Generic Name
- Levoketoconazole
- NDC Code (Product)
72065-003- Manufacturer
- Xeris Pharmaceuticals, Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA214133
- Drug Class
- Cortisol Synthesis Inhibitor [EPC]
- Marketing Start
- 12/30/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Recorlev used for?
Recorlev contains Levoketoconazole. It is a tablet taken oral. Consult your doctor for specific uses.
Is Recorlev a controlled substance?
Recorlev is not classified as a controlled substance by the DEA.
What is the generic name for Recorlev?
The generic name for Recorlev is Levoketoconazole. There are no other listed brand versions of Levoketoconazole.
What is the NDC code for Recorlev 150 mg/1?
The NDC (National Drug Code) for Recorlev 150 mg/1 is 72065-003, listed by Xeris Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)